3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
9
Colorectal Neoplasms
7
Rectal Neoplasms
5
Colorectal Cancer Metastatic
5
Ovarian Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Colonic Neoplasms
3
Uveal Melanoma
2
Melanoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 2
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Macular Degeneration
1
Interventions
Radiotherapy
11
Cisplatin
10
Paclitaxel
9
pembrolizumab
7
Fluorouracil
7
Oxaliplatin
6
Irinotecan
6
tislelizumab
5
Cetuximab
5
Docetaxel
4
Radiation
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
Capecitabine
3
Neoadjuvant Therapy
2
Immunohistochemistry
2
Biopsy
2
10-propargyl-10-deazaaminopterin
2
tremelimumab
1
sitravatinib
1
sintilimab
1
regorafenib
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
durvalumab
1
cixutumumab
1
adavosertib
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Squamous Cell Carcinoma
×
aflibercept
×
Clear all
No trials found.